W20 Buys Healthcare Social Media Analyst Symplur

Healthcare marcoms specialist W20 has acquired social media analytics platform Symplur, which also operates exclusively in the healthcare sector. Terms of the deal have not been disclosed.

Headquartered in Pasadena, California, Symplur tracks how physicians and other healthcare stakeholders produce and consume medical information online. The firm's proprietary Healthcare Social Graph database comprises tens of thousands of healthcare topics with billions of conversations, around any given therapeutic area among millions of influencers in real time. Additional capabilities include influencer analyses, stakeholder segmentation, classification and engagement analyses.

W20 says the acquisition will expand its own proprietary data and technology platform and corresponding solutions. Symplur, which will now operate as W2O symplur, adds a team of software architects and developers to the W2O group, as well as Symplur co-founders Audun Utengen and Thomas Lee (pictured left to right), who will continue to serve in leadership roles.

Jim Weiss, W20 founder and CEO comments: 'Symplur's technology products turn up the volume on the most important, and overlooked, voices in healthcare, ultimately engineering a path to a deeper understanding of this dynamic, complex sector. Symplur is another in a series of strategic investments in people, technology and platforms that we've made, and intend to make, to strengthen the solutions we provide to clients. W2O now has hundreds of people focused in technology, data science, audience analytics, activation and measurement and we will double down in this space going forward'.

Web sites: www.w2ogroup.com and www.symplur.com .